Angle (AGL) RNS Announcements

Add to Alert list
Date Time Source Announcement
07 Mar 2019 07:00 AM
RNS
ENROLMENT COMPLETE FOR FDA CLINICAL STUDY
28 Feb 2019 07:00 AM
RNS
FIRST SUBJECTS ENROLLED IN OVARIAN CANCER STUDY
25 Feb 2019 07:00 AM
RNS
CUSTOMER DEMONSTRATES NEW USE FOR PARSORTIX
11 Feb 2019 07:00 AM
RNS
Research into role of immune cells in cancer
31 Jan 2019 07:00 AM
RNS
Interim Results
29 Jan 2019 07:00 AM
RNS
NEW APPLICATION FOR PARSORTIX IN CANCER ANALYSIS
11 Jan 2019 02:05 PM
RNS
Second Price Monitoring Extn
11 Jan 2019 02:00 PM
RNS
Price Monitoring Extension
11 Jan 2019 11:05 AM
RNS
Second Price Monitoring Extn
11 Jan 2019 11:00 AM
RNS
Price Monitoring Extension
11 Jan 2019 09:05 AM
RNS
Second Price Monitoring Extn
11 Jan 2019 09:00 AM
RNS
Price Monitoring Extension
10 Jan 2019 04:41 PM
RNS
Second Price Monitoring Extn
10 Jan 2019 04:36 PM
RNS
Price Monitoring Extension
10 Jan 2019 04:01 PM
RNS
BREAKTHROUGH CANCER RESEARCH USING PARSORTIX
09 Jan 2019 07:00 AM
RNS
Notice of Results
21 Dec 2018 07:00 AM
RNS
Issue of LTIP Options and Share Options
28 Nov 2018 07:00 AM
RNS
LEADING US HEMATOPATHOLOGIST APPOINTED AS ADVISOR
13 Nov 2018 05:10 PM
RNS
Holding(s) in Company
05 Nov 2018 07:00 AM
RNS
Acquisition of outstanding shares
02 Nov 2018 02:00 PM
RNS
Price Monitoring Extension
01 Nov 2018 07:00 AM
RNS
Appointment of Dr Jan Groen as NED
30 Oct 2018 04:21 PM
RNS
Result of AGM
29 Oct 2018 07:00 AM
RNS
PARSORTIX SHOWS CAPABILITY TO HARVEST FETAL CELLS
25 Oct 2018 07:00 AM
RNS
Good Progress with FDA Studies
09 Oct 2018 07:00 AM
RNS
Notice of AGM
28 Aug 2018 07:00 AM
RNS
Parsortix shows evidence of CTCs in glioblastoma
25 Jul 2018 07:00 AM
RNS
Preliminary Results for year ended 30 April 2018
24 Jul 2018 05:42 PM
RNS
EIS/VCT Advance Assurance and Total Voting Rights
18 Jul 2018 10:34 AM
RNS
Result of General Meeting
02 Jul 2018 07:00 AM
RNS
Notice of Preliminary Results
25 Jun 2018 06:20 PM
RNS
Results of Fundraising
25 Jun 2018 02:58 PM
RNS
Close of Accelerated Bookbuild
25 Jun 2018 07:50 AM
RNS
Proposed Placing of New Ordinary Shares
04 Jun 2018 07:00 AM
RNS
ENCOURAGING PROGRESS IN ANG-002 FDA CLINICAL STUDY
14 May 2018 07:00 AM
RNS
Leading cancer surgeon appointed
03 May 2018 07:00 AM
RNS
Angle & QIAGEN Poster
19 Apr 2018 07:00 AM
RNS
Parsortix in multiple presentations at AACR
19 Apr 2018 07:00 AM
RNS
Breakthrough Research with Parsortix
05 Apr 2018 07:00 AM
RNS
First patient enrolled in FDA study
26 Mar 2018 04:35 PM
RNS
Price Monitoring Extension
26 Mar 2018 07:00 AM
RNS
Research Update
06 Feb 2018 07:00 AM
RNS
ANGLE plc: RESEARCH GRANT FROM ABBOTT
31 Jan 2018 07:00 AM
RNS
Interim Results
16 Jan 2018 07:00 AM
RNS
WEBINAR:USING PARSORTIX TO TEST DRUGS ON LIVE CTCS
10 Jan 2018 10:16 AM
RNS
Notice of Results
08 Jan 2018 07:00 AM
RNS
ANGLE plc:Prostate cancer ARV7 treatment biomarker
27 Dec 2017 11:49 AM
RNS
Holding(s) in Company
12 Dec 2017 07:00 AM
RNS
Transfer of Lock-in Shares
08 Dec 2017 07:00 AM
RNS
PARSORTIX POTENTIAL IN METASTATIC BREAST CANCER

ANGLE PLC is a commercially driven specialist medical diagnostic company with pioneering products in cancer diagnostics and foetal health. The Company's product includes Parsortix cell separation system.

Founded in 1994, AGL share price listed on LSE in 2004 under the ticker AGL.

UK 100